CASI Pharmaceuticals (NASDAQ:CASI) Research Coverage Started

Stock analysts at StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Get Rating) in a report issued on Friday. The firm set a “hold” rating on the biotechnology company’s stock. A number of other equities research analysts have also recently commented on the stock. HC Wainwright reduced their target price on shares of […]

Related Keywords

China , Wellington , New Zealand General , New Zealand , United States , , Geode Capital Management , Goldman Sachs Group Inc , Virtu Financial , Nasdaq , Pharmaceuticals Get Rating , Pharmaceuticals Inc , Citigroup Inc , Wellington Shields Co , Get Rating , Sachs Group , Capital Management , Casi Pharmaceuticals , Nasdaq Casi , Casi , Medical , Initiated Coverage , Stocknews Com ,